Table 3.
Mitigation of secondary stress response (catalase and superoxide dismutase) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature for 105 days.
| Treatments | Non-stressors | Stressors (arsenic and temperature) | Non-stressors | Stressors (arsenic and temperature) | P-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Diets | Control | Control | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | |
| CAT-Liver | 3.96d ± 0.26 | 6.70f. ± 0.61 | 2.29c ± 0.19 | 0.91a ± 0.13 | 4.24e ± 0.31 | 2.13c ± 0.24 | 1.29b ± 0.11 | 6.39f. ± 0.18 | 0.0023 |
| CAT-Gill | 3.11c ± 0.40 | 8.44d ± 0.61 | 1.61b ± 0.25 | 0.78a ± 0.08 | 3.04c ± 0.53 | 1.52b ± 0.28 | 0.81a ± 0.07 | 3.21c ± 0.59 | 0.014 |
| CAT-Kidney | 5.73c ± 0.76 | 9.01d ± 0.38 | 2.68b ± 0.29 | 1.04a ± 0.15 | 5.09c ± 0.41 | 2.22b ± 0.31 | 1.20a ± 0.19 | 9.47d ± 0.92 | 0.002 |
| SOD-Liver | 66.0b ± 1.82 | 75.04d ± 1.14 | 66.71b ± 1.16 | 62.02a ± 1.13 | 70.85c ± 1.09 | 66.75b ± 1.50 | 62.59a ± 0.58 | 72.07c ± 0.91 | 0.034 |
| SOD-Gill | 31.49a ± 1.23 | 38.71b ± 0.58 | 30.63a ± 1.44 | 32.01a ± 1.40 | 30.31a ± 1.84 | 32.26a ± 0.80 | 30.15a ± 1.96 | 30.84a ± 1.46 | 0.027 |
| SOD-Kidney | 41.16a ± 1.29 | 46.66b ± 2.16 | 42.32a ± 1.54 | 40.57a ± 0.98 | 43.34ab ± 1.25 | 40.97a ± 0.95 | 41.0a ± 1.52 | 47.15b ± 1.46 | 0.043 |
Values in the same row with different superscript (a, b, c, d, e, f) differ significantly. Data expressed as Mean ± SE (n = 6). Catalase and SOD: Units/mg protein.